A further study reported upregulation in PD-L1 levels in CD133+CD44+ colorectal (CRC) cells and even higher in CD133+ CD44+ colorectal CSCs and CSC-enriched tumor spheres [79]. The gene discussed is CD44; the disease is colorectal carcinoma.